Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine)
D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism; D002997:Clomipramine / Q000494:pharmacology; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D010133:p-Chloroamphetamine / Q000037:antagonists & inhibitors
D010879:Piperazines; D011719:Pyrazines; D012701:Serotonin; C014896:6-chloro-2-(1-piperazinyl)pyrazine; D010133:p-Chloroamphetamine; D002997:Clomipramine; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine